Senti Biosciences (SNTI) Institutional Ownership $3.97 -0.01 (-0.25%) (As of 12/20/2024 05:40 PM ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Senti Biosciences (NASDAQ:SNTI)CurrentInstitutional OwnershipPercentage25.73%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$17.70MNumber ofInstitutional Sellers(last 12 months)3TotalInstitutional Outflows(last 12 months)$17.47M Get SNTI Insider Trade Alerts Want to know when executives and insiders are buying or selling Senti Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data SNTI Institutional Buying and Selling by Quarter Ad Stansberry Research$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being carried out by the Fed that has nothing to do with lowering or raising interest rates... but could soon have an enormous impact on your wealth.Click here to see his new research now. Senti Biosciences Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/14/2024 NEA Management Company LLC442,615$1M0.1%-90.0%9.664% 11/7/2024 8VC GP I LLC253,755$573K0.8%-90.0%5.541% 10/31/2024 ARK Investment Management LLC176,666$399K0.0%-88.9%3.858% 7/26/2024 ARK Investment Management LLC1,585,772$438K0.0%-2.8%34.624% 2/12/2024 8VC GP I LLC2,537,558$1.68M1.7%N/A5.697% 1/17/2024 ARK Investment Management LLC1,969,860$1.30M0.0%+7.9%4.423% 10/27/2023 TD Asset Management Inc241,208$102K0.0%+88.4%0.542% 9/7/2023 Triatomic Management LP300,533$188K0.2%+42.5%0.675% 7/10/2023 ARK Investment Management LLC1,829,815$1.15M0.0%-3.8%4.143% 5/3/2023 Triatomic Management LP210,883$249K0.2%+39.0%0.477% 4/17/2023 ARK Investment Management LLC1,901,467$2.24M0.0%-1.3%4.305% 2/14/2023 Triatomic Management LP151,675$214K0.2%+168.7%0.346% 2/13/2023 Artal Group S.A.55,555$78K0.0%-94.7%0.127% 2/7/2023 TD Asset Management Inc118,292$167K0.0%-12.3%0.270% 1/24/2023 ARK Investment Management LLC1,925,827$2.72M0.0%-7.8%4.391% 11/15/2022 Triatomic Management LP56,454$123K0.1%N/A0.129% 11/7/2022 TD Asset Management Inc.134,892$285K0.0%+53.8%0.308% 11/3/2022 The Manufacturers Life Insurance Company117,707$248K0.0%N/A0.269% 10/17/2022 ARK Investment Management LLC2,087,696$4.53M0.0%N/A4.771% 8/11/2022 Artal Group S.A.1,055,555$2.07M0.1%N/A4.450% 8/8/2022 Allen Operations LLC21,443$42K0.0%N/A0.090% 8/4/2022 TD Asset Management Inc.87,696$172K0.0%N/A0.370% 7/29/2022 Kingfisher Capital LLC113,163$222K0.1%N/A0.477% (Data available from 1/1/2016 forward) SNTI Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of SNTI shares? During the previous two years, the following institutional investors and hedge funds held shares of Senti Biosciences shares: NEA Management Company LLC ($1M), 8VC GP I LLC ($573K), ARK Investment Management LLC ($399K), Triatomic Management LP ($188K), and TD Asset Management Inc ($102K), Artal Group S.A. ($78K).Learn more on SNTI's institutional investors. What percentage of Senti Biosciences stock is owned by institutional investors? 25.73% of Senti Biosciences stock is owned by institutional investors. Learn more on SNTI's institutional investor holdings. Which institutional investors have been buying Senti Biosciences stock? The following institutional investors have purchased Senti Biosciences stock in the last 24 months: 8VC GP I LLC ($2.54M), Triatomic Management LP ($244.08K), ARK Investment Management LLC ($143.79K), and TD Asset Management Inc ($113.17K). How much institutional buying is happening at Senti Biosciences? Institutional investors have bought a total of 3,038,594 shares in the last 24 months. This purchase volume represents approximately $20.77M in transactions. Which Senti Biosciences major shareholders have been selling company stock? The following institutional investors have sold Senti Biosciences stock in the last 24 months: NEA Management Company LLC ($3.98M), 8VC GP I LLC ($2.28M), ARK Investment Management LLC ($1.71M), Artal Group S.A. ($1M), and TD Asset Management Inc ($16.60K). How much institutional selling is happening at Senti Biosciences? Institutional investors have sold a total of 8,996,076 shares in the last 24 months. This volume of shares sold represents approximately $34.83M in transactions. Related Companies Rani Therapeutics Major Shareholders Anixa Biosciences Major Shareholders Adagene Major Shareholders Assertio Major Shareholders 23andMe Major Shareholders PowerUp Acquisition Major Shareholders CytomX Therapeutics Major Shareholders Karyopharm Therapeutics Major Shareholders Adlai Nortye Major Shareholders Reviva Pharmaceuticals Major Shareholders This page (NASDAQ:SNTI) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Senti Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Senti Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
